ALLERGIC RHINITIS IN CHILDREN AND ADOLESCENTS AGED 5–17 YEARS: KEY LINKS IN THE ATOPIC MARCH, CLINICAL AND DIAGNOSTIC FEATURES, AND MANAGEMENT STRATEGIES
DOI:
https://doi.org/10.11603/24116-4944.2025.1.15409Keywords:
allergic rhinitis, pediatric allergy, comorbidity, bronchial asthma, atopic dermatitis, allergic conjunctivitis, urban environment, genetic predisposition, ARIA protocol, symptom severity, seasonal variation, intranasal corticosteroids, antihistamines, combination therapy, quality of life, psycho-emotional impact, sleep disturbances, nasal obstruction, Visual Analogue Scale (VAS), allergic multimorbidity, environmental factors, pediatric outpatient studyAbstract
The aim of the study – a comprehensive study of allergic rhinitis as one of the key stages of the atopic march in children and adolescents aged 5 to 17 years based on the analysis of clinical data of patients included in our own research.
Materials and Methods. This study was conducted from January to April 2025 in a pediatric outpatient setting involved 198 children, of whom 42 aged 5–17 years had allergic rhinitis (AR) symptoms. Participants were categorized by age, gender, social-territorial factors, and clinical features for comprehensive analysis. The middle age group (10–13 years) accounted for the highest prevalence (40.5 %), indicating age-related susceptibility. Boys slightly predominated (55 %), consistent with global trends in early allergic disease development. Seasonal analysis revealed 60 % of cases during winter, likely due to viral infections exacerbating AR, and 40 % in spring, correlating with pollen exposure. Urban residence predominated (75 %), reflecting environmental risk factors like pollution. Genetic predisposition was significant, with 65 % having a family history of allergic diseases, associated with more severe and prolonged symptoms. Comorbidities were frequent: bronchial asthma (28 %), allergic conjunctivitis (32 %), atopic dermatitis (4.7 %), otitis media (18 %), sinusitis (12 %), and adenoiditis (10 %), highlighting the allergic multimorbidity concept. Clinical symptoms included serous rhinorrhea (90 %), sneezing (81.6 %), nasal itching (75 %), obstruction (70 %), and ophthalmic symptoms (58.3 %), reflecting the classical AR presentation. The ARIA (AR and its Impact on Asthma) protocol enabled effective diagnosis and stratification: 65 % had persistent rhinitis, 35 % intermittent.
Results and Discussion. Treatment response to intranasal corticosteroids and antihistamines was positive in 85 % within 5–7 days, supporting trial therapy’s diagnostic role. Combined therapy (antihistamines plus corticosteroids) showed superior efficacy, improving quality of life by 85 % versus 65 % and 48 % in monotherapy groups. Psycho-emotional impact was significant, with sleep disturbances, attention deficits, anxiety, and depressive symptoms noted, adversely affecting academic and social functioning. Oxygen saturation monitoring revealed mild nocturnal hypoxia in 22 %, linking nasal obstruction to impaired ventilation.
Conclusions. The study underscores the need for early diagnosis, personalized management, and comprehensive care addressing comorbidities and psychosocial effects in pediatric AR, especially in urban environments with genetic and environmental risk factors.
References
1. Vitte, J., Vibhushan, S., Bratti, M., Montero-Hernandez, J. E., & Blank, U. (2022). Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 31(6), 501–515. https://doi.org/10.1159/000527481
2. Moustaki, M., Loukou, I., Tsabouri, S., & Douros, K. (2022). The links between allergen exposure and sensitization in children and adolescents: an overview for the clinician. Expert review of clinical immunology, 18(6), 581–590. https://doi.org/10.1080/1744666X.2022.2072297
3. Ptaschinski, C., & Gibbs, B. F. (2024). Early-life risk factors which govern pro-allergic immunity. Seminars in immunopathology, 46(3-4), 9. https://doi.org/10.1007/s00281-024-01020-x
4. Davis, E. C., Jackson, C. M., Ting, T., Harizaj, A., & Järvinen, K. M. (2022). Predictors and biomarkers of food allergy and sensitization in early childhood. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 129(3), 292–300. https://doi.org/10.1016/j.anai.2022.04.025
5. Tedner, S. G., Asarnoj, A., Thulin, H., Westman, M., Konradsen, J. R., & Nilsson, C. (2022). Food allergy and hypersensitivity reactions in children and adults-A review. Journal of internal medicine, 291(3), 283–302. https://doi.org/10.1111/joim.13422
6. Pieren, D. K. J., Boer, M. C., & de Wit, J. (2022). The adaptive immune system in early life: The shift makes it count. Frontiers in immunology, 13, 1031924. https://doi.org/10.3389/fimmu.2022.1031924
7. Kelly, M. S., Bunyavanich, S., Phipatanakul, W., & Lai, P. S. (2022). The Environmental Microbiome, Allergic Disease, and Asthma. The journal of allergy and clinical immunology. In practice, 10(9), 2206–2217.e1. https://doi.org/10.1016/j.jaip.2022.06.006
8. Huang, Y. J., Porsche, C., Kozik, A. J., & Lynch, S. V. (2022). Microbiome-Immune Interactions in Allergy and Asthma. The journal of allergy and clinical immunology. In practice, 10(9), 2244–2251. https://doi.org/10.1016/j.jaip.2022.05.038
9. Liu, X., Wu, R., Fu, Y., Chen, W., Chen, Y., Yan, Y., Bi, J., & Liu, J. (2022). Meta-analysis of early-life antibiotic use and allergic rhinitis. Open medicine (Warsaw, Poland), 17(1), 1760–1772. https://doi.org/10.1515/med-2022-0459
10. Duong, Q. A., Pittet, L. F., Curtis, N., & Zimmermann, P. (2022). Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis. The Journal of infection, 85(3), 213–300. https://doi.org/10.1016/j.jinf.2022.01.005
11. R. J. Vieira, B. Sousa-Pinto, J. Bousquet, et al., “ Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments,” Allergy 81, no. 6 (2026): 1947–1970. https://doi.org/10.1111/all.70305
12. Bousquet, J., Anto, J.M., Bachert, C. et al. Allergic rhinitis. Nat Rev Dis Primers 6, 95 (2020). https://doi.org/10.1038/s41572-020-00227-0
13. Sousa-Pinto, B., Savouré, M., Vieira, R. J., Amaral, R., Czarlewski, W., Bedbrook, A., Valiulis, A., Kvedariene, V., Brussino, L., Gemicioglu, B., Haahtela, T., Klimek, L., Kraxner, H., Larenas-Linnemann, D. E., Pfaar, O., Regateiro, F. S., Samolinski, B., Taborda-Barata, L., Toppila-Salmi, S., Ventura, M. T., … Bousquet, J. (2025). Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users. Journal of investigational allergology & clinical immunology, 35(5), 373–383. https://doi.org/10.18176/jiaci.1047
14. Paller, A. S., Spergel, J. M., Mina-Osorio, P., & Irvine, A. D. (2019). The atopic march and atopic multimorbidity: Many trajectories, many pathways. The Journal of allergy and clinical immunology, 143(1), 46–55. https://doi.org/10.1016/j.jaci.2018.11.006
15. Tham, E. H., & Leung, D. Y. (2019). Mechanisms by Which Atopic Dermatitis Predisposes to Food Allergy and the Atopic March. Allergy, asthma & immunology research, 11(1), 4–15. https://doi.org/10.4168/aair.2019.11.1.4
16. Hill, D. A., & Spergel, J. M. (2018). The atopic march: Critical evidence and clinical relevance. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 120(2), 131–137. https://doi.org/10.1016/j.anai.2017.10.037
17. Irmak, S., Dedeoglu, S., Toprak, S. F., Sırma, E., Samancı, S., & Kozan, G. (2026). Intranasal Corticosteroids Versus Second-Generation Antihistamines for Allergic Rhinitis in Adolescents: A Prospective Cohort Study of Quality of Life and School Attendance. Journal of asthma and allergy, 19, 606463. https://doi.org/10.2147/JAA.S606463
18. Lee, M., Boyce, J. A., & Barrett, N. A. (2025). Cysteinyl Leukotrienes in Allergic Inflammation. Annual review of pathology, 20(1), 115–141. https://doi.org/10.1146/annurev-pathmechdis-111523-023509
19. Klain, A., Indolfi, C., Dinardo, G., Licari, A., Cardinale, F., Caffarelli, C., Manti, S., Ricci, G., Pingitore, G., Tosca, M., Decimo, F., & Miraglia Del Giudice, M. (2021). United airway disease. Acta bio-medica : Atenei Parmensis, 92(S7), e2021526. https://doi.org/10.23750/abm.v92iS7.12399
20. Yamani, I., Bu Saeed, K., Alsulami, A., Sait, S., & Althumali, A. H. (2024). Efficacy of Biologic Therapies in the Management of Allergic Rhinitis: A Systematic Review. Cureus, 16(10), e71408. https://doi.org/10.7759/cureus.71408
21. Sousa-Pinto, B., Bousquet, J., Vieira, R. J., Schünemann, H. J., Zuberbier, T., Bognanni, A., Togias, A., Samolinski, B., Valiulis, A., Williams, S., Bedbrook, A., Czarlewski, W., Torres, M. J., Shamji, M. H., Morais-Almeida, M., Canonica, G. W., Vecillas, L. L., Dykewicz, M. S., Jacomelli, C., Klimek, L., … Fonseca, J. A. (2026). Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments. Allergy, 81(4), 954–976. https://doi.org/10.1111/all.70131
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Я. Д. Бондаренко, Д. Є. Кулик, М. К. Бірюкова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
